Table 1.
Glaucoma group | Model | AIC | AUC | Sensitivity | Specificity | CC* | PIL* |
---|---|---|---|---|---|---|---|
All | NFI** | 120.88 | 0.914 | 87.8 | 84.2 | 86.5 | 0.180 |
TSNIT | 126.58 | 0.902 | 79.7 | 93.4 | 82.4 | 0.189 | |
NAP-FDT | 129.12 | 0.881 | 83.8 | 86.8 | 78.4 | 0.165 | |
FDT | 129.00 | 0.853 | 83.8 | 86.8 | 78.4 | 0.163 | |
CDR | 102.90 | 0.931 | 93.2 | 81.6 | 85.1 | 0.137 | |
Multivariable | 88.28 | 0.959 | 94.6 | 89.5 | 83.8 | 0.147 | |
| |||||||
Early | NFI** | 102.26 | 0.872 | 87.9 | 80.3 | 80.4 | 0.178 |
TSNIT | 101.40 | 0.854 | 72.7 | 86.8 | 76.8 | 0.199 | |
NAP-FDT | 109.98 | 0.796 | 69.7 | 86.8 | 71.4 | 0.162 | |
FDT | 103.67 | 0.783 | 69.7 | 86.8 | 71.4 | 0.155 | |
CDR | 79.32 | 0.908 | 87.9 | 81.6 | 80.4 | 0.186 | |
Multivariable | 76.06 | 0.930 | 87.9 | 89.5 | 82.1 | 0.240 | |
| |||||||
Moderate | NFI** | 44.16 | 0.961 | 95.8 | 92.1 | 95.2 | 0.105 |
TSNIT | 49.49 | 0.946 | 91.7 | 94.7 | 92.9 | 0.124 | |
NAP-FDT | 55.56 | 0.929 | 91.7 | 92.1 | 81.0 | 0.104 | |
FDT | 61.80 | 0.893 | 91.7 | 86.8 | 71.4 | 0.155 | |
CDR | 50.99 | 0.936 | 91.7 | 90.8 | 92.9 | 0.112 | |
Multivariable | 39.37 | 0.983 | 100 | 88.2 | 83.3 | 0.125 | |
| |||||||
Severe | NFI | 39.14 | 0.931 | 88.2 | 94.7 | 100 | 0.106 |
TSNIT | 44.12 | 0.932 | 94.1 | 93.4 | 93.2 | 0.134 | |
NAP-FDT** | 36.48 | 0.976 | 94.1 | 97.4 | 88.6 | 0.079 | |
FDT | 38.07 | 0.934 | 100 | 86.8 | 77.3 | 0.110 | |
CDR | 37.13 | 0.968 | 100 | 81.6 | 84.1 | 0.122 | |
Multivariable | 30.62 | 0.986 | 100 | 92.1 | 88.6 | 0.121 |
AIC, Akaike’s information criterion; AUC, area under the curve; CC, proportion subjects correctly classified; PIL, median prediction interval length; NFI, nerve fiber indicator; TSNIT, average RNFL; NAP-FDT, number of abnormal points on FDT; FDT, normal or abnormal; CDR, cup-to-disc ratio.
Calculated using the validation set;
Best single variable model